Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy

Sleep

Volumn 35, Issue 9, 2012, Pages 1247-1255

  Andlauer, Olivier ^a,b,c   Moore IV, Hyatt ^a   Hong, Seung Chul ^d   Dauvilliers, Yves ^e   Kanbayashi, Takashi ^f   Nishino, Seiji ^a   Han, Fang ^g   Silber, Michael H ^h   Rico, Tom ^a   Einen, Mali ^a   Kornum, Birgitte R ^a,i   Jennum, Poul ⁱ   Knudsen, Stine ⁱ   Nevsimalova, Sona ^j   Poli, Francesca ^k   Plazzi, Giuseppe ^k   Mignot, Emmanuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c University Hospital of Besançon   (France)

^d The Catholic University of Korea   (South Korea)

^e GUI DE CHAULIAC HOSPITAL   (France)

^f AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^h Mayo Clinic College of Medicine   (United States)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j CHARLES UNIVERSITY   (Czech Republic)

^k UNIVERSITY OF BOLOGNA   (Italy)

more..

Author keywords

Hypocretin; Low csf hypocretin 1; MSLT; Narcolepsy without cataplexy; Polysomnography; REM latency

Indexed keywords

HLA DQB1 ANTIGEN; OREXIN A;

ADULT; AFRICAN AMERICAN; ARTICLE; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DAYTIME SOMNOLENCE; DISEASE DURATION; EPWORTH SLEEPINESS SCALE; EXPERIMENTAL TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SLEEP LATENCY TEST; NARCOLEPSY; ONSET AGE; PARASOMNIA; POLYSOMNOGRAPHY; PREDICTOR VARIABLE; PRIORITY JOURNAL; REM SLEEP; RETROSPECTIVE STUDY; SLEEP; SURVIVAL RATE;

ADULT; AGE OF ONSET; BIOLOGICAL MARKERS; CONTINENTAL POPULATION GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NARCOLEPSY; NEUROPEPTIDES; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SLEEP STAGES; SURVIVAL ANALYSIS;

EID: 84865708520     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2080     Document Type: Article

References (45)

1. Oka Y, Inoue Y, Kanbayashi T, et al. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings. Sleep 2006;29:1439-43. (Pubitemid 44764669)
2. Hong SC, Lin L, Jeong JH, et al. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness. Sleep 2006;29:1429-38. (Pubitemid 44764668)
3. Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997;20:1012-20. (Pubitemid 28042450)
4. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40. (Pubitemid 30072183)
5. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-62.
6. Silber MH, Krahn LE, Olson EJ, Pankratz VS. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 2002;25:197-202. (Pubitemid 34193581)
7. Hublin C, Kaprio J, Partinen M, et al. The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort. Ann Neurol 1994;35:709-16. (Pubitemid 24172171)
8. Ohayon MM, Priest RG, Zulley J, Smirne S, Paiva T. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 2002;58:1826-33. (Pubitemid 34663586)
9. Shin YK, Yoon IY, Han EK, et al. Prevalence of narcolepsy-cataplexy in Korean adolescents. Acta Neurol Scand 2008;117:273-8. (Pubitemid 351369263)
10. Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001;18:78-105. (Pubitemid 32549906)
11. Cao M. Advances in narcolepsy. Med Clin North Am 2010;94:541-55.
12. Richardson GS, Carskadon MA, Flagg W, Van den Hoed J, Dement WC, Mitler MM. Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 1978;45:621-7. (Pubitemid 9031575)
13. Mitler MM, Van den Hoed J, Carskadon MA, et al. REM sleep episodes during the Multple Sleep Latency Test in narcoleptic patients. Electroencephalogr Clin Neurophysiol 1979;46:479-81. (Pubitemid 9126960)
14. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-24. (Pubitemid 17131209)
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders - 4th ed., text revised. Washington: American Psychiatric Association, 2000.
16. American Academy of Sleep Medicine. The International Classification of Sleep Disorders, Revised. Rochester, MN: American Academy of Sleep Medicine, 1997.
17. Aldrich MS, Chervin RD, Malow BA. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 1997;20:620-9. (Pubitemid 27449600)
18. Chervin RD, Aldrich MS. Sleep onset REM periods during multiple sleep latency tests in patients evaluated for sleep apnea. Am J Respir Crit Care Med 2000;161(2 Pt 1):426-31. (Pubitemid 30129448)
19. American Academy of Sleep Medicine. International Classification of Sleep Disorders: Diagnostic and Coding Manual, 2nd ed. Westchester, IL, 2005.
20. Krahn LE, Pankratz VS, Oliver L, Boeve BF, Silber MH. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep 2002;25:733-6. (Pubitemid 35216087)
21. Dauvilliers Y, Baumann CR, Carlander B, et al. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry 2003;74:1667-73. (Pubitemid 37542057)
22. Heier MS, Evsiukova T, Vilming S, Gjerstad MD, Schrader H, Gautvik K. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway. Sleep 2007;30:969-73. (Pubitemid 47221896)
23. Martinez-Rodriguez JE, Iranzo A, Casamitjana R, Graus F, Santamaria J. [Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia]. Med Clin (Barc) 2007;128:361-4.
24. Knudsen S, Jennum PJ, Alving J, Sheikh SP, Gammeltoft S. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population. Sleep 2010;33:169-76.
25. Nevsimalova S, Jara C, Prihodova I, Kemlink D, Sonka K, Skibova J. Clinical features of childhood narcolepsy. Can cataplexy be foretold? Eur J Paediatr Neurol 2011.
26. Mignot E, Lin L, Finn L, et al. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain 2006;129(Pt 6):1609-23. (Pubitemid 43999391)
27. Singh M, Drake CL, Roth T. The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep 2006;29:890-5.
28. Gibbs JW, 3rd, Ciafaloni E, Radtke RA. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Sleep 2002;25:662-5.
29. Manni R, Politini L, Nobili L, et al. Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors. Clin Neurophysiol 2001;112:800-5. (Pubitemid 32406255)
30. Billiard M, Bassetti C, Dauvilliers Y, et al. EFNS guidelines on management of narcolepsy. Eur J Neurol 2006;13:1035-48. (Pubitemid 44434309)
31. Bourgin P, Zeitzer JM, Mignot E. CSF hypocretin-1 assessment in sleep and neurological disorders. Lancet Neurol 2008;7:649-62.
32. Kanbayashi T, Shimohata T, Nakashima I, et al. Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications. Arch Neurol 2009;66:1563-6.
33. Anic-Labat S, Guilleminault C, Kraemer HC, Meehan J, Arrigoni J, Mignot E. Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep 1999;22:77-87. (Pubitemid 29097901)
34. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
35. Littner MR, Kushida C, Wise M, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 2005;28:113-21. (Pubitemid 40543126)
36. Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009;41:708-11.
37. Kleinbaum DG, Klein M. Survival Analysis. A self-Learning Text. 2nd ed. New York: Springer, 2005.
38. Thannickal TC, Nienhuis R, Siegel JM. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep 2009;32:993-8.
39. Okun ML, Lin L, Pelin Z, Hong S, Mignot E. Clinical aspects of narcolepsy- cataplexy across ethnic groups. Sleep 2002;25:27-35. (Pubitemid 34072656)
40. Nakamura M, Kanbayashi T, Sugiura T, Inoue Y. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels. J Sleep Res 2011;20(1 Pt 1):45-9.
41. Baumann CR, Khatami R, Werth E, Bassetti CL. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy. J Neurol Neurosurg Psychiatry 2006;77:402-4.
42. Nevsimalova S, Buskova J, Kemlink D, Sonka K, Skibova J. Does age at the onset of narcolepsy influence the course and severity of the disease? Sleep Med 2009;10:967-72.
43. Dauvilliers Y, Montplaisir J, Molinari N, et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 2001;57:2029-33. (Pubitemid 33126870)
44. Nevsimalova S. Narcolepsy in childhood. Sleep Med Rev 2009;13:169-80.
45. Marti I, Valko PO, Khatami R, Bassetti CL, Baumann CR. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome. Sleep Med 2009;10:1146-50.